MT1002透析抗凝临床II期首例入组，化解370万透析患者“防堵”与“出血”两难

MT1002完成Ib/II期首例患者入组 急性缺血性卒中临床研究迈入新阶段

First Patient Enrolled in Phase Ib/II Trial of MT1002; Acute Ischemic Stroke Clinical Study Enters New Stage

坚守临床数据生命线｜麦科奥特标准化 HIS 溯源质控体系，筑牢多肽新药研发合规根基

Guard the Lifeline of Clinical Data | MICOT Standardized HIS Traceability Quality Control System Consolidates Compliance Foundation for Polypeptide New Drug

行业观察报道：西北药王笃定中国创新药，7年磨一剑穿越周期登陆港股

Industry Insight: Northwest China’s Pharma Champion Bets Big on Chinese Innovative Drugs, Secures HK Listing After Seven Years of Steady Growth Through Market Cycles